Lv2
178 积分 2024-08-28 加入
Statistics notes: Analysing controlled trials with baseline and follow up measurements
5天前
已完结
A new rating scale for Alzheimer's disease
5天前
已完结
Glymphatic dysfunction links vascular pathology to Alzheimer's biomarkers and cognitive decline
11天前
已完结
Safety and effectiveness of lecanemab in Chinese patients with early Alzheimer's disease: Evidence from a multidimensional real-world study
18天前
已完结
Baseline amyloid deposition phenotypes inform the spatial distribution of early amyloid clearance with lecanemab in Alzheimer’s disease
25天前
已完结
Multimodal Integration of Gait Dysfunction, Amyloid PET, and Plasma Biomarkers for Differentiating Etiological Subtypes in Mild Cognitive Impairment
26天前
已完结
Cortical thickness changes precede high levels of amyloid by at least 7 years
28天前
已完结
A Voxel-Based Morphometric Pilot Study of Longitudinal Hippocampal and Cortical Changes during Sequential Lecanemab to Donanemab Therapy
29天前
已完结
Heterogeneity in plasma p‐tau217 response and its association with cognitive trajectories under lecanemab treatment
29天前
已完结
Baseline Amyloid PET Centiloid Score and Risk of Amyloid-Related Imaging Abnormalities in Patients Treated With Lecanemab
1个月前
已完结
皖公网安备34019202002308
